Kymera Therapeutics Inc. to Participate in Stifel Virtual Immunology and Inflammation Forum
I'm PortAI, I can summarize articles.
Kymera Therapeutics Inc. will participate in the Stifel 2025 Virtual Immunology and Inflammation Forum on September 15 at 12:30 p.m. ET. The company, known for developing oral small molecule degrader medicines for immunological diseases, will engage in a fireside chat. Live webcasts will be available on their website, with replays post-event. This news was generated by Public Technologies and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments